An abstract in the upcoming European Conference on Clinical Microbiology and Infectious Diseases (ECCMID) has gotten a fair bit of press and led to a lot of questions because of some sensational headlines. I’ll hopefully be able to check out all the details at ECCMID (I’ll be there for the Global Leaders Group on AMR
Being asked to coordinate a paper for the Journal of Law, Medicine & Ethics wasn’t on my academic bingo card for the year, but like a lot of things in recent years, I’ve come to expect the unexpected. The paper in question is part of a special edition entitled Addressing Antimicrobial Resistance through the Proposed
The antibiotic development pipeline is drying up. More companies are abandoning the area because antibiotics are expensive to develop and license, but they are low profit drugs that we try to use as little as possible.
This is a big issue for human medicine, and was the focus of a lot of discussion at this
I’ve written (ranted?) about this before – namely the misuse of antimicrobials intended for treatment of aquarium fish in other species. Usually such posts are followed by a deluge of nasty emails along with a bunch of curious requests for links to fish antibiotic sellers (8% kickback available!).
Another sponsorship request came in this morning
How do I link all those? It’s not as big of a stretch as you might think, but it’s definitely getting into some theoretical components.
Dogs are unique from a Lyme disease perspective in that healthy individuals are very commonly tested.
Hundreds of thousands of dogs get tested every year for heartworm, and common heartworm
As World Antimicrobial Awareness Week 2022 winds down, I’ll touch on a statement that I’ve seen a lot over the past week. “We need to reduce misuse and overuse of antibiotics” or “Misuse and overuse of antibiotics are driving antimicrobial resistance (AMR).” Those are great sound bites but largely miss
I’m focusing on antimicrobials this week since it’s World Antimicrobial Awareness Week, but this is a timely topic and there’s an antimicrobial twist.
A couple of recent reports about a canine pneumovirus outbreak in a shelter in Tacoma WA and a separate outbreak of canine pneumovirus in a shelter in Las Vegas NV have,
I’ve spent a lot of time in meetings listening to people debating whether to use the word “antibiotic” vs “antimicrobial.” I tend to stay out of those discussions because I don’t care too much either way.
As we start World Antimicrobial Awareness Week, I’m going to try to write a few posts about various aspects of antimicrobial use and resistance in animals. This first post is a bit long, but it covers an important topic: antimicrobial use targets.
I get asked a lot about whether antimicrobial use targets are need
If you follow zoonotic diseases, you might look at the title of this post and think “What is he rehashing now? We already know Salmonella is common in reptiles, and contact with reptiles is a major risk factor for salmonellosis in people.”
In large part, you’d be right. Not a lot has changed
